We invest in
Purpose that Performs
Omicelo invests in businesses that increase access to healthcare, housing, wealth creation, and a thriving environment – delivering value profitably and at scale.
Oakwell® is a real estate and infrastructure firm providing capital, engineering, and project delivery services to healthcare and higher education institutions. Oakwell unlocks significant savings that expand access to patient care and drive student success. The company was formed in partnership with Boston Medical Center Health System.
Havenside exists to improve the appearance, comfort, safety and long-term value of your home – your biggest asset. Havenside performs renovations, remodels, safety and accessibility improvements and handyman services for homeowners and their families.
VISION + VALUES
VISION:
By 2035, Omicelo will empower our portfolio companies and strategic relationships to directly impact the lives of one million people.
We are Passionate About our Core Values
Trust is Our Currency
We are committed to our responsibilities and to conducting ourselves with sincere integrity – doing what we say we are going to do when we say we are going to do it. This commitment to integrity anchors the trust that we foster between teammates internally as well as with our clients and partners. This trust is the currency that our firm will draw on to sustain and grow.
Listening is Our Strategic Advantage
We listen first and fashion our solutions around what our customers need – this is how we best meet our mission. Our purposeful listening approach applies to our customers as well as our teams: by opening our ears we multiply our problem-solving capabilities – each person learns from the diverse life and professional experiences that make up our team thereby preserving time and capital.
Strong Partnerships are Our Winning Strategy
Our success depends on mutually beneficial partnerships within our team, with our partners, and with our customers. We create an atmosphere where teamwork is celebrated and doing “it” on your own is only for special situations. Finally, we ensure that our incentives are aligned with our partners and customers in a way that helps us meet our mission.
Our Innovation Multiplies Our Impact
We employ a differentiated decision-making approach that weighs three factors equally: mission alignment, scalability, and economic viability. To do this well, we expend significant energy creating the quickest path for accurate information to flow throughout our company. Making the best, information-rich decisions at the optimum time grows our ability to meet our mission exponentially.
Investment Approach
Mission Alignment
Omicelo employs a ‘missional radar’ to identify and collaborate with scalable, mission-aligned stakeholders.
Comprehensive Due Diligence
Omicelo is committed to evidence-based decision-making, using intensive data and research to scale returns.
Financial Innovation
Omicelo attracts private market investors, fund managers, corporations, health systems, and government agencies to realize competitive financial returns while advancing our mission.
Transparent Accountability
Omicelo is forthright in our investment processes, financial reporting, and initiative outcomes submitting to the highest level of accountability to all stakeholders.
Leadership
Joshua Pollard
Managing Partner, Chief Executive Officer
Joshua is the founder and CEO of Omicelo, a private investment group making strategic investments that directly increase access to quality healthcare, viable housing, wealth creation opportunities, and a thriving environment. Prior to founding Omicelo, Joshua led Goldman Sachs’ housing research team through the Great Recession and was a critical member of their universal research team covering real estate, alternative energy, and other global sectors. During his time at Goldman Sachs, Joshua led the research efforts of a $1 billion IPO and received numerous awards including being named to Forbes Magazine’s inaugural 30 under 30 list.
Kathleen Feeney
Managing Partner, Chief Operating Officer
Jeffrey Wilde
Managing Partner, Chief Financial Officer
Jeffrey leads the integrated finance and data science efforts of Omicelo, a combination that sets Omicelo’s investment capabilities apart from other investment groups. Prior to joining the firm, Jeffrey was a Vice President at The Carlyle Group and the lead portfolio manager for two real estate funds in excess of $2 billion. He built proprietary economic predictive models using advanced statistical coding programs and acquired a unique combination of business skills to help companies scale alongside the finance acumen to lead accounting and reporting teams. Jeffrey also served as a Repo Trader at GMAC RFC Securities and a Quantitative Analyst for Corporate Executive Board before it was acquired by Gartner Inc.
Contact Us
We want to get to know you.
Let’s talk about how we can work together to bring real, life-changing improvements to your business.
412.376.4000
171 Industry Dr
Pittsburgh, PA 15275
